The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTI1.L Regulatory News (TI1)

  • There is currently no data for TI1

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Investment in Ferguson plc

13 Jun 2019 07:00

RNS Number : 0374C
Trian Investors 1 Limited
13 June 2019
 

June 13, 2019

Trian Investors 1 Limited

Statement Regarding Investment in Ferguson plc

The board of Trian Investors 1 Limited (the "Company"; LSE: TI1) today announces that funds managed by Trian Fund Management, L.P. and Trian Investors Management, LLC (collectively, "Trian"), including a fund managed by Trian in which the Company is the principal investor (the "Partnership"), have acquired in aggregate a 5.98% interest in the shares of Ferguson plc (LSE: FERG.L) as of June 12, 2019, valued at approximately GBP 736 million (U.S. $935 million). Trian believes that Ferguson is an attractive business that trades at a discount to comparable U.S. peers. Trian has contacted members of Ferguson's management team and looks forward to working with them to explore and implement initiatives that it believes can create long-term shareholder value.

The Company's board notes that it previously approved Trian's recommendation of a potential investment in Ferguson, and as of June 12, 2019, the Company has invested approximately GBP 250 million (U.S. $317 million) in Ferguson through the Partnership, at an average cost basis of GBP 52.85 per share. Trian has advised the Company that it may increase or decrease its investment in Ferguson from time to time in the future based on various factors, including market conditions and Trian's evaluation of the investment prospects of Ferguson. In addition, because Ferguson receives the vast majority of its revenue in U.S. Dollars, Trian has advised the Company that it currently expects to utilize a currency hedge to offset a portion of the Company's U.S. Dollar exposure as a result of its investment in Ferguson, although there is no assurance that such hedging transaction will be entered into, or will be effective at managing currency exposure if entered into.

The Company's board notes that Trian submitted a TR-1 notification to Ferguson that disclosed that as of June 10, 2019, funds managed by Trian, including the Partnership, had acquired in the aggregate a 5.14% interest in the shares of Ferguson.

This announcement includes inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). Estera International Fund Managers (Guernsey) Limited, the Company's Administrator and Corporate Secretary, is responsible for arranging for the release of this announcement on behalf of the Company.

About Trian Investors 1 Limited

The Company is a Guernsey domiciled limited company with ordinary shares admitted for trading on the Specialist Fund Segment of the London Stock Exchange. Its investment manager is Trian Investors Management, LLC, whose parent is Trian Fund Management, L.P. The Company's investment objective is to generate significant capital appreciation through Trian's operational and strategic perspectives as a highly engaged shareowner.

 

Enquiries:

Greenbrook Communications Limited

Andrew Honnor, Andrew Dowler, Rob White

+44 20 7952 2000

Trian Investors Management, LLC

Anne A. Tarbell

(212) 451-3030

atarbell@trianpartners.com

Cautionary note regarding forward-looking statements

This announcement contain statements which are, or may be deemed to be, "forward-looking statements" or "forward-looking information" under applicable securities laws (collectively referred to as "forward-looking statements"). Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements.

The forward-looking statements contained in this announcement include statements relating to the creation of long-term shareholder value in Ferguson and Trian's decision to increase or decrease the Company's investment in Ferguson. Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "plans", "expects" or "does not expect", "is expected", "is subject to", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, the Company can give no assurance that such expectations will prove to be correct. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements.

The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STREAFKAFFKNEAF
Date   Source Headline
26th Apr 20234:22 pmRNSNotice of EGM Results
26th Apr 20234:21 pmRNSNotice of AGM Results
26th Apr 20237:30 amRNSSuspension - Trian Investors 1 Limited
17th Apr 20235:03 pmRNSNet Asset Value as at 31 March 2023
6th Apr 20232:55 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSTotal Voting Rights
24th Mar 20237:01 amRNSNotice of EGM
24th Mar 20237:00 amRNSNotice of AGM
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
17th Mar 20237:00 amRNSAnnual Report to 31 December 2022
16th Mar 202312:08 pmRNSNAV as at 28 February 2023 and as at 13 March 2023
14th Mar 20232:43 pmRNSTotal Voting Rights
2nd Mar 20237:00 amRNSCompulsory Share Redemption Update
22nd Feb 20232:53 pmRNSNet Asset Value as at 16 February 2023
22nd Feb 20232:37 pmRNSNet Asset Value as at 31 January 2023
17th Feb 20237:00 amRNSCompulsory Share Redemption Update
1st Feb 20237:00 amRNSTotal Voting Rights
19th Jan 20237:00 amRNSIn-specie Distribution & Complusory Redemption
19th Jan 20237:00 amRNSNet Asset Value as at 6 January 2023
9th Jan 20236:01 pmRNSNet Asset Value as at 31 December 2022
9th Jan 20237:00 amRNSCompulsory Share Redemption Update
14th Dec 20225:26 pmRNSNet Asset Value as at 30 November 2022
11th Nov 20224:34 pmRNSNet Asset Value as at 31 October 2022
26th Oct 20225:16 pmRNSReplacement - Net Asset Value(s)
25th Oct 20224:16 pmRNSNet Asset Value as at 30 September 2022
24th Oct 20228:51 amRNSHolding(s) in Company
15th Sep 20227:00 amRNSInterim Results
14th Sep 20227:00 amRNSNet Asset Value as at 31 August 2022
6th Sep 202210:42 amRNSHolding(s) in Company
2nd Sep 20227:00 amRNSCompulsory Share Redemption by 30 June 2023
15th Aug 20225:30 pmRNSChanges to Director Roles and Responsibilities
12th Aug 20227:00 amRNSNet Asset Value as at 31 July 2022
8th Aug 20227:00 amRNSResult of EGM
8th Aug 20227:00 amRNSDirector Changes
8th Aug 20227:00 amRNSResult of AGM
11th Jul 20222:01 pmRNSNotice of AGM
11th Jul 20222:00 pmRNSNotice of Requisitioned EGM
11th Jul 20227:00 amRNSNet Asset Value as at 30 June 2022
1st Jul 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20223:56 pmRNSReceipt of Requisition Notice
15th Jun 20227:00 amRNSNet Asset Value as at 31 May 2022
31st May 20228:00 amRNSInvestment in Unilever
6th May 20226:00 pmRNSNet Asset Value as at 30 April 2022
14th Apr 20227:01 amRNSDirector Appointment
14th Apr 20227:00 amRNSAnnual Report to 31 December 2021
13th Apr 20225:53 pmRNSNet Asset Value as at 31 March 2022
29th Mar 202210:11 amRNSNew US$100m Revolving Credit Facility
16th Mar 20224:53 pmRNSNet Asset Value as at 28 February 2022
1st Mar 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.